TTNP
Price
$3.53
Change
+$0.09 (+2.62%)
Updated
Dec 18, 04:00 PM (EDT)
VIGL
Price
$1.65
Change
-$0.08 (-4.62%)
Updated
Dec 18, 04:59 PM (EDT)
92 days until earnings call
Ad is loading...

TTNP vs VIGL

Header iconTTNP vs VIGL Comparison
Open Charts TTNP vs VIGLBanner chart's image
Titan Pharmaceuticals
Price$3.53
Change+$0.09 (+2.62%)
Volume$100
CapitalizationN/A
Vigil Neuroscience
Price$1.65
Change-$0.08 (-4.62%)
Volume$3.51K
CapitalizationN/A
TTNP vs VIGL Comparison Chart
Loading...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TTNP vs. VIGL commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TTNP is a Hold and VIGL is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (TTNP: $3.44 vs. VIGL: $1.73)
Brand notoriety: TTNP and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TTNP: 432% vs. VIGL: 167%
Market capitalization -- TTNP: $3.14M vs. VIGL: $70.72M
TTNP [@Biotechnology] is valued at $3.14M. VIGL’s [@Biotechnology] market capitalization is $70.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TTNP’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 1 green FA rating(s).

  • TTNP’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, VIGL is a better buy in the long-term than TTNP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TTNP’s TA Score shows that 4 TA indicator(s) are bullish while VIGL’s TA Score has 3 bullish TA indicator(s).

  • TTNP’s TA Score: 4 bullish, 4 bearish.
  • VIGL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TTNP is a better buy in the short-term than VIGL.

Price Growth

TTNP (@Biotechnology) experienced а -5.23% price change this week, while VIGL (@Biotechnology) price change was -23.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

TTNP is expected to report earnings on Feb 28, 2024.

VIGL is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($70.7M) has a higher market cap than TTNP($3.15M). VIGL YTD gains are higher at: -48.817 vs. TTNP (-58.303). TTNP has higher annual earnings (EBITDA): -7.09M vs. VIGL (-87.97M). VIGL has more cash in the bank: 111M vs. TTNP (4.09M). TTNP has less debt than VIGL: TTNP (0) vs VIGL (13.2M). TTNP (0) and VIGL (0) have equivalent revenues.
TTNPVIGLTTNP / VIGL
Capitalization3.15M70.7M4%
EBITDA-7.09M-87.97M8%
Gain YTD-58.303-48.817119%
P/E RatioN/AN/A-
Revenue00-
Total Cash4.09M111M4%
Total Debt013.2M-
FUNDAMENTALS RATINGS
TTNP: Fundamental Ratings
TTNP
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TTNPVIGL
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 23 days ago
79%
Bullish Trend 13 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARQT14.861.29
+9.51%
Arcutis Biotherapeutics
VIPS13.410.20
+1.51%
Vipshop Holdings Limited
USAP44.30-0.05
-0.11%
Universal Stainless & Alloy Products
HON233.13-2.87
-1.22%
Honeywell International
VTGN2.43-0.05
-2.02%
VistaGen Therapeutics

TTNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TTNP has been loosely correlated with INM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TTNP jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TTNP
1D Price
Change %
TTNP100%
+1.47%
INM - TTNP
46%
Loosely correlated
N/A
ORMP - TTNP
28%
Poorly correlated
-1.67%
SPHRY - TTNP
27%
Poorly correlated
+8.81%
CDTX - TTNP
27%
Poorly correlated
-1.93%
RVPH - TTNP
26%
Poorly correlated
-39.13%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with OABI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then OABI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
-7.49%
OABI - VIGL
34%
Loosely correlated
-0.79%
ALEC - VIGL
33%
Loosely correlated
-4.55%
TTNP - VIGL
31%
Poorly correlated
+1.47%
VIR - VIGL
31%
Poorly correlated
-2.78%
BEAM - VIGL
30%
Poorly correlated
-1.21%
More